BioRestorative Therapies Inc 9OF0
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 1.38M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.59
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
- Website
- https://www.biorestorative.com
Valuation
|
Metric
|
9OF0
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.21 |
Price/Sales | 4.59 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
9OF0
|
|---|---|
Quick Ratio | 2.23 |
Current Ratio | 2.35 |
Interest Coverage | — |
Quick Ratio
9OF0
Profitability
|
Metric
|
9OF0
|
|---|---|
Return on Assets (Normalized) | −187.10% |
Return on Equity (Normalized) | −376.00% |
Return on Invested Capital (Normalized) | −374.73% |
Return on Assets
9OF0
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|%>$qq& | LOCK|$&Dj | $128B | |||
| Moderna Inc
MRNA
| LOCK|WxYQ>R@ | LOCK|z>P | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|ck$D^K? | LOCK|sW?% | $76B | |||
| argenx SE ADR
ARGX
| LOCK|^BS?P?q | LOCK|Md | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|#jMshSW | LOCK|SZQ | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Sc%w!#? | LOCK|NTz%& | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|&%%PnTQ | LOCK|g^D# | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|^P!<>$ | LOCK|!z# | $24B | |||
| Incyte Corp
INCY
| LOCK|>Tb%$Fv | LOCK|qZ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|cL>>d@ | LOCK|q< | $15B |
United States